Ariad Pharmaceuticals Inc fka ARIA

[jbog]

biotechrocks,

I think we're going to sit in this area until something becomes real. I've owned both Aria and Exel for years and both these stocks performed within fractions of each other for years.

This year Exel not only received approvals but its initial sales are running way ahead of projections. As a result Exel's stock has become one of the better performers. Their results are real.

Hopefully, early next year Ariad will start to follow an similar path and then it can obtain a marketcap similar to Exel which is about double todays cap.


Good Luck